Hypothesis

3 Matching Annotations

Jan 2026
www.sciencedirect.com www.sciencedirect.com

Targeting senescent EGR1+ B cells enhances immunotherapy efficacy in esophageal squamous cell carcinoma

1
1. scibot 06 Jan 2026
  
  in Public
  
  RRID:AB_2566331
  
  DOI: 10.1016/j.xcrm.2025.102532
  
  Resource: (BioLegend Cat# 505036, RRID:AB_2566331)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2566331
  
  What is this?
  
  RRID:AB_2566331
Visit annotations in context

Tags

RRID:AB_2566331

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379125006056
Jan 2023
www.sciencedirect.com www.sciencedirect.com

Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8+ T cells and reprogramming macrophages

1
1. scibot 12 Jan 2023
  
  in Public
  
  RRID:AB_2566331
  
  DOI: 10.1016/j.immuni.2022.12.006
  
  Resource: (BioLegend Cat# 505036, RRID:AB_2566331)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2566331
  
  What is this?
  
  RRID:AB_2566331
Visit annotations in context

Tags

RRID:AB_2566331

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1074761322006422
Sep 2022
www.sciencedirect.com www.sciencedirect.com

Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity

1
1. scibot 16 Sep 2022
  
  in Public
  
  RRID:AB_2566331
  
  DOI: 10.1016/j.ccell.2022.08.014
  
  Resource: (BioLegend Cat# 505036, RRID:AB_2566331)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2566331
  
  What is this?
  
  RRID:AB_2566331
Visit annotations in context

Tags

RRID:AB_2566331

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610822003786